Carisma Therapeutics Inc.

NASDAQ: CARM · Real-Time Price · USD
0.45
-0.05 (-10.41%)
At close: Jun 20, 2025, 3:59 PM
-10.41%
Bid 0.44
Market Cap 18.75M
Revenue (ttm) 16.23M
Net Income (ttm) -50.77M
EPS (ttm) -1.22
PE Ratio (ttm) -0.37
Forward PE -0.68
Analyst Hold
Ask 0.44
Volume 2,680,813
Avg. Volume (20D) 13,863,579
Open 0.48
Previous Close 0.50
Day's Range 0.43 - 0.56
52-Week Range 0.14 - 1.90
Beta 2.79

About CARM

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CARM
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CARM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Carisma Therapeutics Inc. is scheduled to release its earnings on Aug 7, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-25.65%
Carisma Therapeutics shares are trading lower afte... Unlock content with Pro Subscription
6 months ago
-12.82%
Carisma Therapeutics shares are trading lower after Baird downgraded the stock from Outperform to Neutral and cut its price target from $10 to $1.